A new service from Aptamer Group promises to reduce biomarker discovery timelines from years to months, reshaping how pharmaceutical and diagnostic companies approach disease marker identification. The platform combines cutting-edge synthetic biology with advanced proteomics to deliver both validated biomarkers and functional binding tools simultaneously.
Siemens Healthineers has launched a comprehensive expansion of its 3gAllergy diagnostic capabilities, introducing nine new component allergens that deliver unprecedented precision in allergy management. Six of these target peanut allergies – the primary culprit behind fatal food-related anaphylaxis – whilst additional components address house dust mites and wheat sensitivities. This enhancement elevates the IMMULITE 2000 […]
FUJIFILM Biosciences has introduced BalanCD HEK293 Perfusion A Medium, the first commercially available cell culture solution specifically optimised for HEK293 cells in perfusion processes. The medium targets gene therapy applications, enabling continuous production of adeno-associated virus (AAV) and lentivirus (LV) vectors with enhanced consistency and scalability.
LUMICKS has launched Avidion, a next-generation Cell Avidity platform designed to address critical gaps in cell therapy development by measuring how immune cells physically engage with tumour targets.
Vapourtec has launched the Peptide-Builder, a benchtop solid-phase peptide synthesis (SPPS) system designed to streamline peptide production in research and clinical laboratories. The automated platform combines compact design with high-throughput capabilities, addressing space constraints whilst maintaining synthesis performance.
AMS Biotechnology (Amsbio) has unveiled an extensive collection of over 325,000 pre-characterised chemical compounds designed to accelerate drug screening applications across discovery and development programmes.
German biotechnology company ProBioGen has been selected to design, construct, and operate the GMP manufacturing facility at Berlin’s new Centre for Gene and Cell Therapies, establishing a critical infrastructure node for translating advanced therapeutic research into clinical applications across Europe.
Bioscience will serve as the exclusive UK and Ireland distributor for Bio X Cell’s premium monoclonal antibody portfolio. The strategic partnership aims to enhance researcher access to high-quality functional antibodies across academic and biotech institutions throughout both regions.
Biotech company, Atelerix, specialising in non-cryogenic cell preservation technology appoints industry leaders Sunil Shah and Dr Catherine Elton to drive commercial scale-up and international market penetration across life sciences sectors.
German research institute BioMed X has announced a collaboration with Danish pharmaceutical giant Novo Nordisk to develop innovative oral formulation technologies for peptide drugs, including GLP-1 receptor agonists. The partnership aims to overcome critical barriers in oral peptide bioavailability through novel retention mechanisms in the lower small intestine. BioMed X, the independent biomedical research institute […]
November 2025
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.